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Abstract
Background: Although the painful shoulder is one of the most common dysfunctions of the
locomotor apparatus, and is frequently treated both at primary healthcare centres and by
specialists, little evidence has been reported to support or refute the effectiveness of the
treatments most commonly applied. According to the bibliography reviewed, physiotherapy, which
is the most common action taken to alleviate this problem, has not yet been proven to be effective,
because of the small size of sample groups and the lack of methodological rigor in the papers
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published on the subject. No reviews have been made to assess the effectiveness of acupuncture
in treating this complaint, but in recent years controlled randomised studies have been made and
these demonstrate an increasing use of acupuncture to treat pathologies of the soft tissues of the
shoulder. In this study, we seek to evaluate the effectiveness of physiotherapy applied jointly with
acupuncture, compared with physiotherapy applied with a TENS-placebo, in the treatment of
painful shoulder caused by subacromial syndrome (rotator cuff tendinitis and subacromial bursitis).
Methods/design:  Randomised controlled multicentre study with blind evaluation by an
independent observer and blind, independent analysis. A study will be made of 465 patients
referred to the rehabilitation services at participating healthcare centres, belonging to the regional
public health systems of Andalusia and Murcia, these patients presenting symptoms of painful
shoulder and a diagnosis of subacromial syndrome (rotator cuff tendinitis and subacromial bursitis).
The patients will be randomised into two groups: 1) experimental (acupuncture + physiotherapy);
2) control (TENS-placebo + physiotherapy); the administration of rescue medication will also be
allowed. The treatment period will have a duration of three weeks. The main result variable will be
the change produced on Constant's Shoulder Function Assessment (SFA) Scale; as secondary
variables, we will record the changes in diurnal pain intensity on a visual analogue scale (VAS),
nocturnal pain intensity on the VAS, doses of non-steroid anti-inflammatory drugs (NSAIDs) taken
during the study period, credibility scale for the treatment, degree of improvement perceived by
the patient and degree of improvement perceived by the evaluator. A follow up examination will
be made at 3, 6 and 12 months after the study period has ended. Two types of population will be
considered for analysis: per protocol and per intention to treat.
Discussion: The discussion will take into account the limitations of the study, together with
considerations such as the choice of a simple, safe method to treat this shoulder complaint, the
choice of the control group, and the blinding of the patients, evaluators and those responsible for
carrying out the final analysis.
Background
Painful shoulder is one of the most common complaints
affecting the locomotor apparatus, and is frequently
attended both at primary healthcare centres and by spe-
cialists. The annual incidence at primary healthcare cen-
tres is 1.2% [1,2]. This pathology, which becomes more
common with age [3] and with the practice of certain
occupations and sports, is evidenced mainly by pain,
restricted movement and strength and by the loss of
shoulder functionality. The incidence on occupational
invalidity, though mentioned by most authors, remains
unknown; only approximate data are available, such as
those provided by Instituto de Biomecánica at Valencia,
which has estimated that 50% of sick leave is accounted
for by muscle or bone injuries in the shoulder or neck.
The most common actions taken at present to relieve the
symptoms of painful shoulder include steroid injections,
physiotherapy, oral NSAIDs and "wait and see"; hardly
any of these measures have been tested scientifically to
demonstrate their effectiveness in this situation [4].
According to the bibliography reviewed, physiotherapy,
which is the most common treatment applied in this case,
has not been conclusively shown to be effective; sample
sizes have been small and methodological rigor lacking
from the papers published in this respect. On the other
hand, solid evidence has been produced that ultrasound
therapy is ineffective in treating the painful shoulder
[1,5,6].
The most relevant bibliography we have examined com-
prises reviews of the question carried out by the Cochrane
group in 2000, 2003 and 2004, together with certain sys-
tematic reviews by other authors. In general, the conclu-
sions of the analysts in the Cochrane studies, and of other
reviewers working for professional organisations, is that
there is very little evidence to support or refute the effec-
tiveness of the treatment commonly applied for the pain-
ful shoulder. Therefore, well-designed studies are
necessary, using uniform methods of diagnosis and meas-
urement to ensure the validity of the results obtained. We
have also analysed other studies, with less backing than
the above-mentioned opinions of expert reviewers, but
with an acceptable methodology, that have concluded in
favour of one or other mode of treatment, such as physio-
therapy [7,8] or the injection of corticoids [9,10]. We have
also examined the recommendations of panels of experts
and members of associations of physiotherapists and GPs.
Acupuncture has been used to treat this type of medical
problem in China for over 3000 years. At present, it is
under consideration as a technique to be applied in West-BMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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ern medical practice for a great many complaints, espe-
cially for cases in which modern techniques are either of
limited effectiveness or are unsuitable [11]. Acupuncture
is now widely used in the treatment of chronic pain [12-
14]. The systematic review carried out by Lewith & Machin
on the effectiveness of acupuncture in treating chronic
pain concluded that treatment with "real" acupuncture
was significantly more effective than that with "false" acu-
puncture and with a placebo [15]. It has also been shown
that acupuncture provokes fewer adverse side effects than
does the use of NSAIDs or opiates [16]. In recent years,
randomised controlled studies have provided further evi-
dence supporting the use of acupuncture in the treatment
of pathologies of the soft tissues of the shoulder. For
example, Kleinhenz et al. [17] observed an improvement
of 19.2 points on Constant's scale for an experimental
group versus one of 8.37 points among a control group,
using a placebo featuring retractable needles, but these
authors seem to have focused more on demonstrating the
effectiveness of the technique used with the control group
than on the specificity of the selection of the acupuncture
points; moreover, with respect to the analysis of the main
result variable (the absolute improvement achieved), the
fit to the baseline measurement was not made. On the
other hand, Sun et al. [18] (did aim to locate the specifi-
city of the points, by selecting a point that was distal from
the affected area, using a randomised controlled test with
two groups; 13 patients were treated with acupuncture
and specific exercises for the shoulder, and another 22
patients were treated solely with exercise. The design of
the latter study is similar to that presented in this project
although we believe the sample size is too small and a sig-
nificant degree of bias was introduced by the fact that the
control group (which received only exercises) did not
receive the same medical attention as the experimental
group. Nevertheless, the results obtained with the experi-
mental group were significantly better than those of the
control group. A further problem is that the point pro-
posed by the authors (Zhongpin of the leg) is difficult to
locate, as its situation is not constant, on the contrary to
that of Tiaokou (ST38), which is situated exactly 8 cun
below the articular line of the knee and 1 cun lateral from
the tibial crest. Another clinical trial was reported by Gil-
bertson et al. [19], who described a case in which, after an
arthroscopic intervention on the shoulder, traditional and
sham acupuncture were compared. It was concluded that
real acupuncture provides a significant improvement,
concerning the degree of analgesia achieved, the reduction
in the quantity of analgesics required, increased mobility
and patient satisfaction; however, the acupuncture points
selected are not described and so the trial is not reproduc-
ible.
Since the introduction of acupuncture techniques into pri-
mary healthcare at the Dos Hermanas "A" Health Centre,
with the establishment of the Pain Treatment Unit, data
have been compiled to obtain an initial evaluation of the
reactions of patients who are given acupuncture treatment
[20]. Moreover, a pilot study has been carried out to assess
the immediate effects of this technique when applied to
cases of supraspinal tendinitis [21] as a previous step to
the development of the present study.
In this article, we describe a randomised, blinded, multi-
centre study carried out with a sufficiently-large sample
group, with systematised, uniform diagnostic criteria,
homogeneous therapeutic interventions including the use
of a placebo for the control group, follow up periods
exceeding three months and validated measurement of
results. We believe such a systematic approach is necessary
to clearly describe the current context of treatment for the
painful shoulder. In the study, we work on the hypothesis
that the acupuncture of Tiaokou ST38, together with phys-
iotherapy, can reduce pain and improve functionality in
situations of subacromial syndrome (rotator cuff tendini-
tis and subacromial bursitis) to a greater extent than does
physiotherapy associated with a TENS-placebo treatment.
The study began in March 2005 and the recruitment phase
remains open.
Methods/design
Design
Randomised controlled multicentre study with blind eval-
uation by an independent observer and blind, independ-
ent analysis.
Study subjects
Patients referred to the Rehabilitation services of the
health centres participating in the study. These centres are
part of the public health systems of the regions of Andalu-
sia and Murcia (Spain). The patients presented chronic
symptoms of subacromial syndrome (rotator cuff tendin-
itis and subacromial bursitis) and were offered treatment
with physiotherapy together with acupuncture or transcu-
taneous stimulus. They were informed of the characteris-
tics of the study and of the techniques to be used, as well
as of the possible risks (infection, lipothymia, hemato-
mas). They were told they could leave the study at any
moment, with no type of penalisation or loss of benefits
to which they were entitled.
Selection criteria
Inclusion criteria
• Patients with a clinical diagnosis of subacromial syn-
drome (rotator cuff tendinitis and subacromial bursitis)
with a case history > 3 months
• Prior radiography, with normal resultsBMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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• Informed consent
• Unilateral injury
Exclusion criteria: surgery, luxations or fractures in the
proximity of the shoulder; other severe direct or indirect
traumas (in traction) observed in the anamnesis and
clearly related to the onset of the current episode; hypoco-
agulates, generalised disorders of the musculoskeletal sys-
tem or neurologic disorders, vascular trophic disorders in
the lower limbs, lymphedema.
Ethical criteria
The ethical validity of this study has been analysed and
approved by the corresponding ethical and research com-
mittees at the healthcare centres involved. The study
design takes into account the Principalism criteria of
Beauchamp & Childress (beneficence, non-maleficence,
autonomy and justice) and expressly guarantees the
patient's right to privacy and informed decision-making.
The study also complies with the norms for Good Clinical
Practice and the Edinburgh 2000 revision of the Helsinki
Declaration. All the patients who participate give their
written, informed consent to the clinical research meth-
ods applied. During the development of the study, audits
will be performed, according to the criteria of the Research
and Ethics Committee and the healthcare centre's Quality
Committee, independently of the external audits
(research funding provider) that may be required.
Criteria and procedures for withdrawal from the study
A patient may be withdrawn from the study at any time,
either at will or by decision of the researcher. The reasons
for interrupting participation in the study will be recorded
on the summary page of the Digital Data Record (DDR).
The following procedure is to be followed when a patient
withdraws from the study:
• Assess the relevant study variables
• Record any adverse events
• Evaluate the taking of rescue medication
• Indicate the possible co-interventions carried out
• Complete the DDR, record the date and reason for with-
drawal.
Randomisation
The patients will be assigned on a random basis to the two
study groups: 1) experimental group treated with acu-
puncture plus physiotherapy; 2) control group, to be
given the TENS placebo plus physiotherapy. Randomisa-
tion will be carried out in each digital data recording sys-
tem. Every healthcare centre participating in the study has
a specially-designed DDR based on a Dell Axim × 30 PDA;
once a new patient's data are entered, the patient is ran-
domly assigned a treatment code (A = experimental; B =
control). This code is concealed from the evaluator. Each
PDA system has three access codes, one for the study con-
troller, one for the evaluator and one for the doctor carry-
ing out the treatment, and only the latter has access to the
treatment code. The research team will take the necessary
measures to ensure the confidentiality of the patients tak-
ing part, including their deidentification within the data-
bases constructed for the analysis.
Interventions
(See Figure 1)
Acupuncture (experimental group): 3 sessions (once 
weekly)
Once a week, before the physiotherapy session, the doc-
tors responsible for the treatment (specialists who are
well-acquainted with the technique) will apply acupunc-
ture at the Tiaokou ST38 point, following the tiao-shan
homolateral technique. This consists of the perpendicular
insertion of a single-use sterile filiform acupuncture nee-
dle, 7.5 cm long, 30 gauge body diameter, using a guide-
tube. The insertion is to be made, after sterilising the skin
and with the patient in a prone position, at the Tiaokou
point (located equidistally from the flexion fold of the
knee and the vertex of the lateral malleolus and 1 inch lat-
erally from the tibial crest, to a depth of 4.5 – 5.0 cm,
towards the Chengshan UB57 point (located on the rear
surface of the leg, half way between the popliteo fold and
the heel, in an inverted-V shaped crease separating the
cords of the external calf. Insertion of the needle is fol-
lowed by vigorous stimulation by means of broad bidirec-
tional rotation movements of the body of the needle,
intended to produce the sensation known as Deqi, often
described as one of irradiance. The needle is maintained
in place for 20 minutes, and manipulated for 1 minute
every 5 minutes (i.e. 4 manipulations per session). While
the needle is being manipulated, the patient should per-
form abduction and external and internal rotation exer-
cises.
The single-use sterile needles are manufactured by Cloud
& Dragaon Radical Device Co., Ltd (Wujiang, China),
according to EU norms, and are imported by Acupuncture
Shop, Storegade 58, 6800 Vade (Denmark).
TENS placebo (control group): three sessions (once 
weekly)
Once a week, before the physiotherapy session, the doc-
tors responsible for the treatment will apply the TENS pla-
cebo, which consists of placing two adhesive electrodes,
one each on the front and rear surfaces of the leg that isBMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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homolateral to the affected shoulder. The electrodes are
connected to a deactivated TENS apparatus, model 8016
M. The stimulation unit remains placed in front of the
patient, such that the flashing of the diode simulating the
stimulus is visible at all times. The patient remains in the
same position for 20 minutes, after which the TENS unit
is disconnected and the electrodes removed from the
patient's body. The frequency of the sessions is the same
as that for acupuncture.
Physiotherapy (experimental and control groups): 15 
sessions (3 weeks)
The physiotherapy sessions last 40 minutes each and con-
sist of the following (see Additional file 1 1 – Physiother-
apy protocol [ISRCTN28687220]):
• Superficial heat therapy (graduated according to the
patient's sensations; 5 minutes)
• Recentering of the humeral head (active manoeuvres: 5
minutes; passive manoeuvres: 5 minutes)
• Diadynamic currents, diphase attached with positive
pole at the point of greatest pain (graduated according to
the patient's sensations; 5 minutes)
• Post-session cryotherapy (10 minutes).
The patient is recommended to avoid any activity that
may cause pain in the affected arm for the duration of the
study. Ultrasound therapy was not included as an applica-
ble technique because it has been shown to be ineffective
in treating pathologies in this region [4].
The daily physiotherapy sessions will follow those of acu-
puncture and the TENS placebo in the following way: first,
a session of acupuncture or TENS placebo followed by the
first one of physiotherapy; the next four sessions of phys-
iotherapy to be applied on following consecutive days.
The second acupuncture or TENS placebo session is
applied prior to the sixth one of physiotherapy, and is fol-
lowed by another four physiotherapy sessions during the
next four consecutive days. The third and final acupunc-
ture or TENS placebo session is applied prior to the elev-
enth one of physiotherapy, and is followed by another
four physiotherapy sessions during the next four consecu-
tive days, after which the final assessment is made. The
acupuncture and the TENS placebo sessions take place in
identical rooms.
Rescue medication
The patients are allowed to take analgesics and/or NSAIDs
if they wish. If they do, this fact, and the daily dose taken,
should be recorded in the digital data record (DDR).
• Anti-inflammatory medication
• If taken, the maximum dose allowed is 1 diclophenac
pill (50 mg) three times a day for a maximum of 4 weeks.
• Administration instructions: to be taken with meals, to
alleviate possible gastric irritation.
• Gastroprotective medication
• Specific indications:
• No past record of ulcers or risk factors such as anticoag-
ulant therapy, association with corticoids, age > 60 years
or severe baseline illness (kidney insufficiency, cirrhosis,
COPD): NO GASTROPROTECTION
• No past record of ulcers and risk factors such as antico-
agulant therapy, association with corticoids, age > 60
years or severe baseline illness (kidney insufficiency, cir-
rhosis, COPD): GASTROPROTECTION with 200 µg mis-
oprostol every 6 or 12 hours or 20 mg famitidine every 12
hours.
• Past record of ulcers: GASTROPROTECTION with 20 mg
omeprazole every 24 hours.
• Contraindications: diclophenac should not be taken by
patients allergic to it, to acetylsalicylic acid or other
NSAIDs, by patients with a history of asthma, angiodema
or rhinitis provoked by NSAIDs, by patients affected by
porphyria or with a history of ulcers, coagulation pathol-
ogies or haemorrhages. Caution is advised for patients
with kidney insufficiency, cardiac insufficiency, hyperten-
sion or liver insufficiency.
Study variables
Baseline assessment (T-0)
For the sake of consistency, criteria of selective tension
and mobility patterns [22]that we believe are clear
enough for homogeneous diagnoses to be achieved (see
Additional file 2) will be applied. When the patient has
been diagnosed, he/she will be invited to give informed
consent to take part in the study. If this is received, the ini-
tial assessment will be made by an external rehabilitation
evaluator, who will record the following data:
• Sociodemographic data
• Age
• Sex
• Influence on the shoulder of the type of work performed
(no effect, moderate effect, severe effect)BMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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• Background
• Previous episodes of shoulder pain (number of epi-
sodes)
• If previous episodes occurred, did they provoke sick
leave? (No. of such events and their duration)
• Current episode
• Concomitant neck pain(yes/no)
• Duration of the present episode (in months)
• Previous treatment received for the same episode (corti-
coid injections, analgesic or anti-inflammatory medica-
tion)
• Acute onset of the present episode (yes/no)
• Direct cause (excessive tension or otherwise, slight
injury or unknown cause)
• Is the affected shoulder the dominant one? (yes/no)
• Constant's Shoulder Function Assessment (SFA) Scale
• Pain intensity in the shoulder during the day, on a 10 cm
Visual Analogue Scale (VAS)
• Pain intensity in the shoulder during the night, on a 10
cm Visual Analogue Scale (VAS)
• Analgesic and NSAID medication taken during the pre-
vious 2 weeks (4 point Likert scale: 0 no medication; 1 less
than the usual daily dose; 2 the normal dose; 3 more than
the normal dose).
Main result variable (endpoint)
At 3 weeks (T-1) after the start of the study, the results of
the intervention will be assessed by an independent expert
evaluator. The 3-month follow up will be performed by
the same evaluator. An additional follow up will be car-
ried out at 6 and 12 months after the final evaluation (by
independent telephone interviewer), including the main
result measurements. These are the change in the SFA
score, with respect to baseline values, after the 15th phys-
iotherapy session. This assessment will be made by an
external rehabilitation specialist with no information
regarding the treatment received by the patient. Con-
stant's Shoulder Function Assessment (SFA) Scale has a
maximum score of 100 points, including subjective and
objective elements in a proportion of 35/65, respectively.
The subjective parameters describe the degree of pain felt
by the patient and his/her ability to carry out normal daily
activities, as regards both the level of activity and the posi-
tion of the arm. The objective parameters are based on the
range of active compound movements that enable the
arm to be moved to functionally relevant positions, using
a goniometer to measure the rear and lateral elevation and
the positioning of the hand in relation to the head and the
trunk in order to assess the degree of rotation achieved.
The score for the power exerted by the shoulder is based
on the weight (in kg) the patient can raise in abduction, to
a maximum of 11 kg. A total SFA score of 100 indicates a
shoulder with perfect freedom of movement, no pain and
normal functioning.
Secondary variables
After the first week of treatment, the level of confidence in
the treatment is measured on a Treatment Credibility
Scale (TCS) [23]. This was first proposed by Borkovec and
Nau [24] and comprised four items that are assessed on a
continuous VAS from 0 to 10 (0 totally disagree; 10 totally
agree). The following elements are included, but at the
baseline interview, only the first two questions are asked:
1. Are you confident this treatment will alleviate the pain
you feel?
2. Does the treatment seem a logical one?
3. Would you recommend this treatment to a friend or rel-
ative who had the same problem?
4. Do you think this treatment could be applied to other
problems?
After three weeks of treatment (T-1) (15 sessions of phys-
iotherapy), the following secondary variables will be
assessed by an independent evaluator:
• Pain intensity in the shoulder during the day, on a 10 cm
VAS (DPI-VAS)
• Pain intensity in the shoulder during the night, on a 10
cm VAS (NPI-VAS)
• Degree of improvement perceived by the patient (IPP)
(7 point Likert categoric scale: 0 much worse; 1 worse; 2
slightly worse; 3 no change; 4 slightly better; 5 better; 6
much better) [25]
• Degree of improvement perceived by the evaluator (IPE)
(7 point Likert categoric scale: 0 much worse; 1 worse; 2
slightly worse; 3 no change; 4 slightly better; 5 better; 6
much better)
• NSAIDs taken (NT)BMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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• Treatment Credibility Scale items 3 and 4
• Adverse events (ADEV) of a traumatic nature that might
distort the results of the evaluation.
Follow up at 3 months after completing the treatment (T-2)
An independent evaluator and rehabilitation specialist
will make the following assessments at 3 months after the
treatment ends:
• Score on Constant's Shoulder Function Assessment
(SFA) Scale
• Pain intensity in the shoulder during the day, on a VAS
(DPI-VAS)
• Pain intensity in the shoulder during the night, on a VAS
(NPI-VAS)
• Degree of improvement perceived by the patient (IPP)
• Degree of improvement perceived by the evaluator (IPE)
• NSAIDs taken (NT)
• Adverse events (ADEV)
• Subsequent episodes of shoulder pain, their duration
and treatment applied.
Follow up at 6 months after completing the treatment, carried out by 
telephone interview (T-3)
An independent evaluator will make the following assess-
ments by telephone interview at 6 months after the treat-
ment ends:
• Score on Constant's Shoulder Function Assessment
(SFA) Scale (only the subjective parameters)
• Pain intensity in the shoulder during the day, on a VAS
(DPI-VAS)
• Pain intensity in the shoulder during the night, on a VAS
(NPI-VAS)
• Degree of improvement perceived by the patient (IPP)
• NSAIDs taken (NT)
• Adverse events (ADEV)
• Subsequent episodes of shoulder pain, their duration
and treatment applied.
Follow up at 12 months after completing the treatment, carried out 
by telephone interview (T-4)
An independent evaluator will make the following assess-
ments by telephone interview at 12 months after the treat-
ment ends:
• Score on Constant's Shoulder Function Assessment
(SFA) Scale (only the subjective parameters)
• Pain intensity in the shoulder during the day, on a VAS
(DPI-VAS)
• Pain intensity in the shoulder during the night, on a VAS
(NPI-VAS)
• Degree of improvement perceived by the patient (IPP)
• NSAIDs taken (NT)
• Adverse events (ADEV)
• Subsequent episodes of shoulder pain, their duration
and treatment applied.
Data collection and analysis
Data collection and recording will be carried out using an
Dell Axim × 30 PDA, fitted with the Windows® operating
system, and specially designed for the purposes of this
study, with obligatory fields, validation rules and quality
control for error avoidance; a 512 bit encoding system is
incorporated to ensure the confidentiality of all the
records. Furthermore, as additional functions, it will
include a security analysis system with stored passwords,
and functions for the export/import and synchronisation
of the database content. Access to this PDA will be limited
to THREE users: 1) the healthcare centre evaluator; 2) the
doctor applying the treatments; 3) the study controller.
Each will have a different access code.
The data tables describing the characteristics of the study
subjects and the results of each of the evaluations will be
entered separately. Each record corresponding to an eval-
uation, after approval by the researcher responsible, will
be stored such that further editing cannot be performed. A
backup copy of the database will be encrypted in a 512 bit
system and uploaded weekly by safe transmission system
to a web server. The study controller will store on the cen-
tral computer the data obtained from each of the partici-
pating healthcare centres and will include all the records
in the central database. Similarly, the study controller will
make a weekly printout of the updated tables from each of
the healthcare centres; these documents will be stored
securely and kept as an original record for purposes of
inspection or auditing or in case of loss of digital data.BMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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Each PDA will be the responsibility of the corresponding
researcher at each health centre.
Sample size and associated power
The sample size was predetermined for a level of signifi-
cance of 0.05, a power of 0.80 and a final average score on
Constant's SFA scale of 70 among the experimental group
(standard deviation 17) and 65 among the control group
(standard deviation 18), with a two-tailed test, according
to data taken from Kleinhenz [17]and Sun [18]. Thus, 188
patients are required for the experimental group and 199
for the control group. Assuming a 20% dropout rate, the
final sample size was set at 226 patients for the experi-
mental group and 239 for the control group [26].
Population
For the purposes of the analysis, two types of population
are to be considered:
• Per intention to treat (ITT): this population will consist
of all the randomised patients. Those taking part in the
selection phase but not subsequently randomised for
treatment will be excluded from this population. This will
comprise the main population for analysis of the parame-
ters of effectiveness.
• Per protocol: this population will consist of all the
patients in the ITT population with no serious deviations
from the protocol. This will comprise the secondary pop-
ulation for analysis.
Treatment comparisons
All the tests will be bilateral and carried out at a level of
significance of α = 0.05. So as not to interrupt the study,
no intermediate analyses are foreseen.
Data analysis
To describe the different baseline characteristics of the
patients, we shall use measures both of position (the
mean or the median, according to the asymmetry) and of
variability (standard deviation or interquartile range) for
the continuous variables, while the others will be
described via their frequency distributions, comparing the
experimental and control groups. Moreover, a graphic
analysis will be made, using smoothed versions of the his-
tograms, boxes and other representations.
For the principal result variable, the difference between
the final value and the baseline Constant SFA score, meas-
ured in absolute terms, the experimental and control
groups will be compared after adjusting by the baseline
value and subsequently by other possible confounders.
This analysis will be repeated in the follow ups at 3, 6 and
12 months. We will evaluate the effect of possible points
of influence by repeating the model after exclusion of the
observations with a large Cook-distance value. The
assumptions of the model will be tested and reanalysed
using a Q-Q plot diagram for the assumption of normal-
ity, and by comparing the studentised residuals versus the
values of the independent variable for the assumption of
constant variances.
For the secondary result variables, the bivariate analysis
will be performed using contingency tables analysed by ji-
squared tests (for tables larger than 2 × 2), by ji-squared
tests corrected for continuity, or Fisher's exact test (for 2 ×
2 tables), for the categoric variables, and by simple linear
regression for all other cases. Two-dimensional graphs
will also be used.
The multivariate analysis will depend on the nature of the
response variable. When this is dichotomic, a binary logis-
tic regression analysis will be made, and for this purpose
we will establish the dummy variables needed for the cat-
egoric predictors. The inclusion of the "experimental
group" or "control group" variable will be forced. The
"forward procedure" method will be used to select the
possible confounding variables in the model, and the
entry criterion used will be the change in the likelihood
ratio. The functional form of the continuous predictors
will be studied via the corresponding statistical criteria,
these being mainly graphic procedures.
For continuous variables, a multiple linear regression
model will be used, and the same model-selection criteria
and diagnostic procedures as described above will be
applied.
Current status of the trial
Recruiting of the patients began in March 2005 and will
continue until December 2005. Follow up is planned to
end in March 2007.
Discussion
We believe that one of the most interesting features of this
study is the fact that it introduces a neurostimulative tech-
nique, and one that is relatively simple to apply, into reha-
bilitative medicine. Nevertheless, we are also aware that
this comprises one of its greatest difficulties, as this alter-
native treatment has been very little used, to date, in this
field. The possibility of extending this clinical practice
into rehabilitation services is one of the challenges we
seek to overcome.
It is very difficult to assess all the aspects that go to make
up chronic pain, as it is such a subjective experience. This
poses problems as regards finding theoretical models and
appropriate measuring instruments, although the correct
application of experts' recommendations will make it pos-
sible to standardise results for later analysis.BMC Complementary and Alternative Medicine 2005, 5:19 http://www.biomedcentral.com/1472-6882/5/19
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There is little evidence to support or refute the effective-
ness of the most common interventions to treat the pain-
ful shoulder. As well as the necessity to carry out further,
well-designed clinical studies, we need to establish a uni-
form means of defining shoulder pathologies and of
developing valid result measurements that are consistent
and adaptable to changes in the population. The choice of
a single type of pathology prevents us from extrapolating
the possible results of research to all the situations in
which painful shoulder is diagnosed. However, the fact of
selecting a single diagnosis will ensure the specificity of
the intervention and will enable us to evaluate particular
aspects of the process.
The clinical studies carried out to examine non conven-
tional medical treatments such as acupuncture pose seri-
ous problems regarding the study design and possible
bias. In selecting the variables to be examined in this
study, we have taken into consideration the previous
experience of the Pain Treatment Unit at the Dos Hermanas
"A" Health Centre and on the comments made in the sys-
tematic reviews of the field made by the Cochrane Group.
The placebo selected differs considerably from the acu-
puncture technique under study, but the intervention in
itself is, in fact, difficult to disguise [27]. The depth of nee-
dle insertion and the manipulations subsequently
effected prevent the use of placebos that are totally credi-
ble [28]. This is why we decided to apply an inactive con-
trol treatment (the TENS placebo), in order to subject the
two groups of patients to the same rhythm of interven-
tion. Nevertheless, the degree of credibility of the inter-
vention and of the placebo will be assessed at the start and
at the end of the study. This type of control was first used
experimentally by Macdonald [29]. The placebo effect is
related to the patient's expectation, to the observer and to
the doctor's attention, in combination with classical Pav-
lovian-type response conditioning activated by the posi-
tive or negative expectation of a cure. Petrie and
Hazleman [30]used a scale to measure the credibility of
acupuncture treatment and that of the TENS placebo, and
reached the conclusion that both methods were equally
credible, thus justifying the use of the TENS placebo as a
control.
Although the characteristics of the intervention prevent us
from establishing a double blind design, we intend to
blind the patients from the evaluator, and believe this
simple blinding will make it possible to achieve sufficient
control of possible bias.
As with any other multicentre study, we are confronted
with certain disadvantages, such as the loss of unity of
judgement, with the participation of various researchers,
or the reduced homogeneity of the sample group and the
parallel increase in data dispersion. In order to overcome
these problems, we have had to create very simple criteria
for patient selection, to avoid possible subjectivity as con-
cerns the different researchers. Additionally, we have laid
great stress on the need to obtain a good level of commu-
nication between the different work groups, a condition
that is sometimes essential to standardise criteria and to
guarantee the internal validity of the study. The best way
to achieve this communication is by means of frequent
meetings, the coordination of which will be the responsi-
bility of the study controller.
The limited number of patients and the restrictions
imposed on the study concerning the criteria for inclusion
are counteracted by its extension to healthcare centres
serving populations living in a different cultural situation,
and to centres that are organised in different ways. Thus,
the external validity of the study is safeguarded.
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